Reply to Muntean et al. Comment on "Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482"

Pathogens. 2022 Jul 5;11(7):767. doi: 10.3390/pathogens11070767.

¹ Department of Clinical Microbiology, Laboratory Dr. Kosak, Dr. Reckendorfer and Partner, 1090 Vienna, Austria.
² Molecular Diagnostics, Center for Health & Bioressources, AIT Austrian Institute of Technology GmbH, 2444 Vienna, Austria.
³ School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
⁴ Clinical Department of Clinical and Molecular Microbiology, University Hospital Center Zagreb, 10000 Zagreb, Croatia.
⁵ Department of Clinical Pathology, Laboratory Dr. Kosak, Dr. Reckendorfer and Partner, 1090 Vienna, Austria.
⁶ Center for Public Health, Department of Environmental Health, Medical University of Vienna, 1090 Vienna, Austria.

Abstract

We appreciate the interest in our publication and agree that a different acronym for the method would have been better [...].

This research received no external funding.